Literature DB >> 22797907

Cerebral sinovenous thrombosis associated with MTHFR A1298C mutation in the newborn: a case report.

Mehmet Nevzat Cizmeci1, Mehmet Kenan Kanburoglu, Ahmet Zulfikar Akelma, Ahsen Donmez, Fatma Mujgan Sonmez, Aziz Polat, Dilek Kosehan, Mustafa Mansur Tatli.   

Abstract

Although cerebral sinovenous thrombosis (CSVT) is a rare condition in the neonatal period, high rates of morbidity and mortality necessitate the establishment of an early diagnosis. Methylenetetrahydrofolate reductase (MTHFR) plays a central role in the folate cycle and mutations of MTHFR are associated with vascular disease. While the C677T common missense mutation is the most well-defined MTHFR polymorphism, another common missense mutation, A1298C also exists. There has been no reported case of CSVT associated with MTHFR A1298C mutation in the neonatal period. Herein, we report a neonate with CSVT who was found to have MTHFR A1298C homozygosity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22797907     DOI: 10.1007/s11239-012-0776-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  10 in total

1.  Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations.

Authors:  James L Rook; Diane J Nugent; Guy Young
Journal:  J Pediatr Hematol Oncol       Date:  2005-11       Impact factor: 1.289

2.  Cerebral sinovenous thrombosis in children.

Authors:  G deVeber; M Andrew; C Adams; B Bjornson; F Booth; D J Buckley; C S Camfield; M David; P Humphreys; P Langevin; E A MacDonald; J Gillett; B Meaney; M Shevell; D B Sinclair; J Yager
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

3.  A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease.

Authors:  R F Franco; V Morelli; D Lourenço; F H Maffei; M H Tavella; C E Piccinato; I A Thomazini; M A Zago
Journal:  Br J Haematol       Date:  1999-05       Impact factor: 6.998

Review 4.  Molecular biology of 5,10-methylenetetrahydrofolate reductase.

Authors:  M Födinger; W H Hörl; G Sunder-Plassmann
Journal:  J Nephrol       Date:  2000 Jan-Feb       Impact factor: 3.902

Review 5.  Neonatal cerebral sinovenous thrombosis: sifting the evidence for a diagnostic plan and treatment strategy.

Authors:  Janet Y K Yang; Anthony K C Chan; David J A Callen; Bosco A Paes
Journal:  Pediatrics       Date:  2010-08-09       Impact factor: 7.124

6.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.

Authors:  I Weisberg; P Tran; B Christensen; S Sibani; R Rozen
Journal:  Mol Genet Metab       Date:  1998-07       Impact factor: 4.797

7.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

8.  Multiple risk factors in neonatal sinovenous thrombosis.

Authors:  Yvonne W Wu; S P Miller; K Chin; A E Collins; S C Lomeli; N A Chuang; A J Barkovich; D M Ferriero
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

9.  Cerebral sinovenous thrombosis in the neonate.

Authors:  Karima C Fitzgerald; Linda S Williams; Bhuwan P Garg; Karen S Carvalho; Meredith R Golomb
Journal:  Arch Neurol       Date:  2006-03

10.  Methionine loading test is necessary for detection of hyperhomocysteinemia.

Authors:  R van der Griend; F J Haas; M Duran; D H Biesma; O J Meuwissen; J D Banga
Journal:  J Lab Clin Med       Date:  1998-07
  10 in total
  3 in total

1.  Lemierre's syndrome with double heterozygote status in the methylenetetrahydrofolate reductase gene.

Authors:  Mostafa Behpour-Oskooee; Abdollah Karimi; Shirin Sayyahfar
Journal:  World J Pediatr       Date:  2014-03-25       Impact factor: 2.764

2.  Hyperhomocysteinemia and MTHFR polymorphisms as antenatal risk factors of white matter abnormalities in two cohorts of late preterm and full term newborns.

Authors:  Lucia M Marseglia; Antonio Nicotera; Vincenzo Salpietro; Elisa Giaimo; Giovanna Cardile; Maria Bonsignore; Angela Alibrandi; Daniela Caccamo; Sara Manti; Gabriella D'Angelo; Carmelo Mamì; Gabriella Di Rosa
Journal:  Oxid Med Cell Longev       Date:  2015-02-10       Impact factor: 6.543

3.  Association study of methylenetetrahydrofolate reductase A1298C mutation with cerebral venous thrombosis risk in an Iranian population.

Authors:  Ghaznavi Habib; Soheili Zahra; Samiei Shahram; Mohammad Soleiman Soltanpour
Journal:  Int J Appl Basic Med Res       Date:  2015 Sep-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.